Integrating metabolic profile and network pharmacology to explore the chemical essence of Radix Ginseng Rubra for attenuating heart failure

• Published in: Arabian journal of chemistry 2024-01, Vol.17 (1), p.105383, Article 105383
• Main Authors: Wang, Yinjie, Han, Wenhui, Feng, Qianyi, Xie, Baolin, Chen, Xiaoshan, Zheng, Zhonghui, Zhao, Zhilong
• Format: Article
• Language: English
• Subjects: In vivo; Metabolism; Network pharmacology; Radix Ginseng Rubra; UPLC-Q-TOF-MS
• ISSN: 1878-5352; 1878-5379
• DOI: 10.1016/j.arabjc.2023.105383

Radix Ginseng Rubra (RGR), a well-known edible-medicinal herb, has been widely used to attenuate heart failure (HF). However, the active ingredients and mechanism of RGR for attenuating HF have not been illuminated. Thus, the metabolic profile in vivo of RGR was investigated by ultra-performance liquid chromatography quadrupole time-of-flight tandem mass spectrometry and further the compounds identified in serum and heart were employed to search for the potential active compounds and targets via network pharmacology and molecular docking. 41 chemical compounds were identified in RGR aqueous extract. 10 prototypes and 8 metabolites were identified or tentatively characterized in vivo. Additionally, two compounds with 51 corresponding targets had been speculated to improve HF, and the role of ginsenoside Rh4 (P8) in RGR for attenuating HF by interfering with MAP2K1 and SRC targets was verified by molecular docking. Therefore, the potential active ingredients and targets were expected to be the basis of RGR therapy for HF.